|
Name |
3-Methoxy-2-methyl-4H-pyran-4-one
|
| Molecular Formula | C7H8O3 | |
| IUPAC Name* |
3-methoxy-2-methylpyran-4-one
|
|
| SMILES |
CC1=C(C(=O)C=CO1)OC
|
|
| InChI |
InChI=1S/C7H8O3/c1-5-7(9-2)6(8)3-4-10-5/h3-4H,1-2H3
|
|
| InChIKey |
NGGPLHHTRNJSDT-UHFFFAOYSA-N
|
|
| Synonyms |
3-Methoxy-2-methyl-4H-pyran-4-one; 4780-14-7; 3-methoxy-2-methylpyran-4-one; 4H-Pyran-4-one, 3-methoxy-2-methyl-; 2-Methyl-3-methoxy-4H-pyran-4-one; 3-methoxy-2-methyl-4-pyrone; 3-Methoxy-2-Methyl-pyran-4-one; SCHEMBL7100551; 3-Methoxy-2-methyl-4-pyranone; DTXSID10343137; ALBB-027294; MFCD14553191; ZINC32179613; AKOS015995164; 3-Methoxy-2-methyl-4H-pyran-4-one #; LS-09349; CS-0153636; D82596; EN300-129191
|
|
| CAS | 4780-14-7 | |
| PubChem CID | 587693 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 140.14 | ALogp: | 0.7 |
| HBD: | 0 | HBA: | 3 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 35.5 | Aromatic Rings: | 1 |
| Heavy Atoms: | 10 | QED Weighted: | 0.591 |
| Caco-2 Permeability: | -4.463 | MDCK Permeability: | 0.00002760 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.003 |
| Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.002 |
| 30% Bioavailability (F30%): | 0.004 |
| Blood-Brain-Barrier Penetration (BBB): | 0.724 | Plasma Protein Binding (PPB): | 76.43% |
| Volume Distribution (VD): | 1.309 | Fu: | 35.01% |
| CYP1A2-inhibitor: | 0.672 | CYP1A2-substrate: | 0.881 |
| CYP2C19-inhibitor: | 0.284 | CYP2C19-substrate: | 0.865 |
| CYP2C9-inhibitor: | 0.027 | CYP2C9-substrate: | 0.653 |
| CYP2D6-inhibitor: | 0.011 | CYP2D6-substrate: | 0.742 |
| CYP3A4-inhibitor: | 0.02 | CYP3A4-substrate: | 0.453 |
| Clearance (CL): | 7.028 | Half-life (T1/2): | 0.792 |
| hERG Blockers: | 0.123 | Human Hepatotoxicity (H-HT): | 0.152 |
| Drug-inuced Liver Injury (DILI): | 0.154 | AMES Toxicity: | 0.202 |
| Rat Oral Acute Toxicity: | 0.699 | Maximum Recommended Daily Dose: | 0.022 |
| Skin Sensitization: | 0.443 | Carcinogencity: | 0.845 |
| Eye Corrosion: | 0.223 | Eye Irritation: | 0.861 |
| Respiratory Toxicity: | 0.757 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000292 | ![]() |
0.545 | D0G4KG | ![]() |
0.356 | ||
| ENC003235 | ![]() |
0.333 | D08SKH | ![]() |
0.327 | ||
| ENC000078 | ![]() |
0.327 | D0N0OU | ![]() |
0.293 | ||
| ENC006095 | ![]() |
0.326 | D0E9CD | ![]() |
0.239 | ||
| ENC006031 | ![]() |
0.321 | D0X0RI | ![]() |
0.216 | ||
| ENC005716 | ![]() |
0.308 | D06GCK | ![]() |
0.215 | ||
| ENC005717 | ![]() |
0.308 | D0L1WV | ![]() |
0.206 | ||
| ENC004675 | ![]() |
0.296 | D0S5CH | ![]() |
0.200 | ||
| ENC001623 | ![]() |
0.291 | D02DPU | ![]() |
0.200 | ||
| ENC000172 | ![]() |
0.286 | D07PAO | ![]() |
0.197 | ||